AVBP — ARRIVENT BIOPHARMA INC

Ownership history in Caption Management, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which Caption Management, LLC reported a position in ARRIVENT BIOPHARMA INC (AVBP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2025 Q3)
Avg. % of fund
0.0%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 7,000 -16,000 -69.6% 0.00% $129K $18.45
2025 Q3 REDUCED 23,000 -17,800 -43.6% 0.00% $424K $18.45
2025 Q3 INITIATED 40,800 — — 0.01% $753K $18.45
% of Fund (quarterly)    AVBP price (monthly, adj. close)

Other funds also holding AVBP

As of 2025 Q4 — sorted by position size

General Catalyst Group Management, LLC 3Y 7Y 13.56% AIHC Capital Management Ltd 12.16% Octagon Capital Advisors LP 3Y 4.81% Novo Holdings A/S 3Y 7Y 3.03% HHLR ADVISORS, LTD. 3Y 7Y 2.55% SUVRETTA CAPITAL MANAGEMENT, LLC 3Y 7Y 1.69% Rosalind Advisors, Inc. 1.53% Sofinnova Investments, Inc. 3Y 7Y 1.47% Fund 1 Investments, LLC 3Y 1.39% ORBIMED ADVISORS LLC 3Y 7Y 1.24%
← Back to Caption Management, LLC Holdings